Table 1 Summary of injection frequency, gain in visual acuity and EXIT after one and 2 years for patients with neovascular age related macular disease (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO). Data are mean ± SEM
nAMD (n = 34) | DME (n = 9) | RVO (n = 16) | ||
|---|---|---|---|---|
Year 1 | injection frequency | 7.4 ± 0.4 | 8.4 ± 1.1 | 7.6 ± 0.5 |
gain in visual acuity [ETDRS] | 7.4 ± 2.2 | 6.1 ± 4.7 | 9.7 ± 4.5 | |
EXIT | 0% | 0% | 0% | |
Year 2 | injection frequency | 12.6 ± 0.7 | 14.0 ± 1.0 | 11.2 ± 0.9 |
gain in visual acuity [ETDRS] | 6.9 ± 2.1 | 11.1 ± 5.1 | 7.5 ± 5.0 | |
EXIT | 29.4% | 0% | 31.3% | |
ETDRS | Baseline | 54.7 ± 3.5 | 56.7 ± 4.4 | 60.3 ± 4.2 |
End | 61.6 ± 3.3 | 67.8 ± 4.3 | 67.8 ± 4.8 | |